Studies | EBMT

Top

Study type

Disease

Group

Type of transplant

Text

Potential factors influencing CAR-T cell manufacturing in terms of production failures and out of specification (OOS) products on behalf of EBMT - CTIWP

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of Stem Cell Treatment

Principal investigator

Defining protective immune cell subsets and subpopulations thresholds following allogeneic hematopoietic stem cell transplantation

Retrospective Studies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of Stem Cell Treatment

Principal investigator

Marina Cavazzana

Stratification of TCE group 3 permissive HLA-DPB1 mismatches in allogeneic hematopoietic cell transplantation

Retrospective Studies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of Stem Cell Treatment

Principal investigator

Esteban Arrieta-Bolaños

Survey on the current use of fecal microbiota transplantation (FMT) in patients with hematologic malignancies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of Stem Cell Treatment

Principal investigator

Graft-versus-Host Disease after donor-derived chimeric antigen receptor T-cell infusion post allogeneic HSCT

Retrospective Studies

Transplant Complications Working Party (TCWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of Stem Cell Treatment

Principal investigator

Guillermo Ortí

Role of HLA Evolutionary Divergence in Mismatched Unrelated Donor Hematopoietic Cell Transplantation for Malignant Hematological Disorders

Retrospective Studies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of Stem Cell Treatment

Principal investigator

Association between HLA evolutionary divergence and leukemia relapse after allogeneic SCT from 10/10 HLA matched related/unrelated donor

Retrospective Studies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of Stem Cell Treatment

Principal investigator

Graft Engineering for allogeneic hematopoietic stem cell transplantation (HSCT) and modified donor lymphocyte infusion (DLI)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of Stem Cell Treatment

Principal investigator

Moniek de Witte

Intrabone infusion of a single umbilical cord blood unit in adults with hematological disease: a Eurocord, CTIWP-EBMT Analysis

Retrospective Studies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of Stem Cell Treatment

Principal investigator

Jacopo Peccatori

Monitoring virus-specific T-cell response in allogeneic hematopoietic stem cell transplant recipients

Retrospective Studies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of Stem Cell Treatment

Principal investigator

Raffaella Greco

Influence of SARS-COV-2 pandemic on handling of allogeneic HPC grafts

Retrospective Studies

Infectious Diseases Working Party (IDWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of Stem Cell Treatment

Principal investigator

Evaluation of killer cell immunoglobulin-like receptor - HLA class I Ligand models for donor selection

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Myelodysplastic (MDS) or MDS/MPN

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of Stem Cell Treatment

Principal investigator

Johannes Schetelig